WuXi AppTec Co., Ltd. (WUXIF)
Data as of October 19, 2026 · Medical - Diagnostics & Research
Stockbruh grade: Challenging 0/5 metrics rated Sunny
What does WuXi AppTec Co., Ltd. do?
WuXi AppTec Co., Ltd., an investment holding firm, specializes in providing a full spectrum of research, development, and manufacturing services. The company's expertise is leveraged globally to facilitate the discovery, advancement, and production of both small molecule pharmaceuticals and innovative cell and gene therapies. Its operational reach extends throughout the People's Republic of China, across the broader Asian continent, within the United States, and across Europe. The organization is structured into six distinct divisions: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and a collective "Others" segment.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ⛅ Moderate | 5-year price performance |
| Profitability | ⛅ Moderate | Net margin & return on equity |
| Growth | ⛅ Moderate | Revenue & earnings trend |
| Earnings | ⛅ Moderate | EPS vs analyst expectations |
| Cash & Debt | ⛅ Moderate | Balance sheet strength |
| Price | $27.00 | Market Cap | — |
| Exchange | OTC | | |
Plain-English Analysis
What's it worth?
Performance has been moderate. Sign up free to see Stockbruh's full valuation analysis including price ratios and plain-English commentary.
How the business works
WuXi AppTec Co., Ltd., an investment holding firm, specializes in providing a full spectrum of research, development, and manufacturing services. The company's expertise is leveraged globally to facilitate the discovery, advancement, and production of both small molecule pharmaceuticals and innovative cell and gene therapies. Sign up free for competitor and revenue breakdown ↗
Are they building the future?
Growth is mixed — some positive signals, but not consistent. Sign up free for Stockbruh's full growth breakdown.
What's ahead?
Earnings are mixed. Sign up free for the full earnings picture including EPS history and analyst forecasts.